Manal Khalid Abdulridha

Publications

• Research Article   
  Clinical Assessment of Oral Curcumin Adjuvant in Post-Ischemic Stroke Patients
  Author(s): Ali Bayyat Abed and Manal Khalid Abdulridha*
  
  Background: The assessment of effectiveness curcumin in patients with ischemic stroke is limited in human studies. Methods: Prospective randomized -controlled open -labeled single -center study was conducted on post stroke patients with or without history of comorbidity from both genders. The eligible patients were allocated into two groups; Group 1 patients on conventional therapy of post-acute ischemic stroke, and group 2:Patients on conventional therapy of post-acute ischemic stroke plus 750 mg Curcumin two capsule single dose daily(1500mg) for 3 months. Muscle Power Scale (MRC), Activism-Stroke Scale, Stroke Specific Quality of Life (SSQOL), and SBP was measured Results: The results in the present study revealed significant improvement up to (71.30%) in muscle power scale in patients with curcumin adjuvant when.. Read More»
  DOI: 10.3371/CSRP. AAMA.111721

  Abstract HTML PDF